Edwards Lifesciences Reports Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Edwards Lifesciences Corporation (EW) Tops Q2 EPS by 10c, Raises Outlook
July 26, 2018 4:22 PM EDTEdwards Lifesciences Corporation (NYSE: EW) reported Q2 EPS of $1.24, $0.10 better than the analyst estimate of $1.14. Revenue for the quarter came in at $972.1 million versus the consensus estimate of $969.02 million.
GUIDANCE:
Edwards Lifesciences Corporation sees Q3 2018 EPS of $0.93-$1.03, versus the consensus of... More
